BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3602316)

  • 1. Behavioral dyscontrol in borderline patients treated with amitriptyline.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Psychopharmacol Bull; 1987; 23(1):177-81. PubMed ID: 3602316
    [No Abstract]   [Full Text] [Related]  

  • 2. Alprazolam-induced dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1986 Apr; 143(4):519-22. PubMed ID: 3513634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report.
    Hooberman D; Stern TA
    J Clin Psychiatry; 1984 Oct; 45(10):441-2. PubMed ID: 6480572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychopharmacology of borderline personality disorders.
    Montgomery SA
    Acta Psychiatr Belg; 1987; 87(3):260-6. PubMed ID: 3673629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for borderline personality disorder.
    Berger PA
    Bull Menninger Clin; 1987 May; 51(3):277-84. PubMed ID: 3580662
    [No Abstract]   [Full Text] [Related]  

  • 11. The psychopharmacologic treatment of personality disorders.
    Klar H; Siever LJ
    Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedative or antimanic effects of carbamazepine and treatment of behavioral dyscontrol.
    Greenberg WM
    Am J Psychiatry; 1986 Nov; 143(11):1486-7. PubMed ID: 3535545
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of borderline patients to loxapine and chlorpromazine.
    Leone NF
    J Clin Psychiatry; 1982 Apr; 43(4):148-50. PubMed ID: 7040351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
    Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
    Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
    J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antabus is unsuitable in treatment of borderline personalities].
    Aberg J
    Lakartidningen; 1984 Oct; 81(41):3684-5. PubMed ID: 6503477
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
    Cowdry RW; Gardner DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating the borderline patient with low-dose neuroleptics.
    Frances A; Soloff PH
    Hosp Community Psychiatry; 1988 Mar; 39(3):246-8. PubMed ID: 3356429
    [No Abstract]   [Full Text] [Related]  

  • 20. Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior.
    Verkes RJ; Pijl H; Meinders AE; Van Kempen GM
    Biol Psychiatry; 1996 Aug; 40(3):173-80. PubMed ID: 8830950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.